Covered recipient · General Payments record
BINDU JAYAVELU
Allopathic & Osteopathic Physicians Internal Medicine Nephrology
General Payments · PY2018–2024
$2,872.05
- Reported across 152 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $447.46 | 22 |
| Education | $55.42 | 3 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $132.81 | 11 |
| BAXTER HEALTHCARE | $123.64 | 1 |
| Ardelyx, Inc. | $57.58 | 3 |
| OPKO Pharmaceuticals, LLC | $38.53 | 2 |
| Acerta Pharma LLC | $28.26 | 2 |
| Janssen Pharmaceuticals, Inc | $26.75 | 1 |
| Aurinia Pharma U.S., Inc. | $24.05 | 1 |
| AKEBIA THERAPEUTICS INC | $23.05 | 1 |
| Otsuka America Pharmaceutical, Inc. | $18.25 | 1 |
| Retrophin, Inc. | $16.89 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $13.07 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AKEBIA THERAPEUTICS INC | $23.05 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145825805 | CMS |
| Amgen Inc. | $12.02 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111609013 | CMS |
| Amgen Inc. | $18.36 | 03/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111609015 | CMS |
| Amgen Inc. | $17.16 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111609017 | CMS |
| Amgen Inc. | $12.45 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111609019 | CMS |
| Amgen Inc. | $11.82 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111609023 | CMS |
| Amgen Inc. | $11.62 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111609021 | CMS |
| Amgen Inc. | $9.36 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111609025 | CMS |
| Amgen Inc. | $4.35 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111609027 | CMS |
| Amgen Inc. | $3.85 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111609029 | CMS |
| Amgen Inc. | $24.64 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111609033 | CMS |
| Amgen Inc. | $7.18 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111609031 | CMS |
| Ardelyx, Inc. | $18.49 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146686851 | CMS |
| Ardelyx, Inc. | $21.93 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146686853 | CMS |
| Ardelyx, Inc. | $17.16 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146686855 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.83 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104604488 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.43 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105578684 | CMS |
| Aurinia Pharma U.S., Inc. | $24.05 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150683648 | CMS |
| Baxter Healthcare | $123.64 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118288495 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $13.07 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086151877 | CMS |
| Janssen Pharmaceuticals, Inc | $26.75 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077913897 | CMS |
| OPKO Pharmaceuticals, LLC | $23.07 | 06/18/2024 | Education | Undisputed | 01/23/2026 | 1112845728 | CMS |
| OPKO Pharmaceuticals, LLC | $15.46 | 07/25/2024 | Education | Undisputed | 01/23/2026 | 1112845730 | CMS |
| Otsuka America Pharmaceutical, Inc. | $18.25 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118915217 | CMS |
| Travere Therapeutics, Inc. | $16.89 | 06/03/2024 | Education | Undisputed | 01/23/2026 | 1149906182 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.